trial · primary record
BIIB147
Amyotrophic Lateral Sclerosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 69 |
| Primary completion | 2034-01-23 |
| Primary endpoint | MAD, OLE, Integrated MAD and OLE Periods: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07855211 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:00.314Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07855211
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.